APA (7th ed.) Citation

F, Z., H, Y., Z, G., H, L., P, W., B, L., . . . J, S. (2025). Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]. Heliyon, 11(16), e44134. https://doi.org/10.1016/j.heliyon.2025.e44134

Chicago Style (17th ed.) Citation

F, Zhao, Yang H, Gao Z, Liu H, Wu P, Li B, Yu H, and Shao J. "Retraction Notice to "Novel Fabrication of Cu(II)-incorporated Chiral D-penicillamine-chitosan Nanocomposites Enantio-selectively Inhibit the Induced Amyloid β Aggregation for Alzheimer's Disease Therapy" [Heliyon 10 (2024) E23563]." Heliyon 11, no. 16 (2025): e44134. https://doi.org/10.1016/j.heliyon.2025.e44134.

MLA (9th ed.) Citation

F, Zhao, et al. "Retraction Notice to "Novel Fabrication of Cu(II)-incorporated Chiral D-penicillamine-chitosan Nanocomposites Enantio-selectively Inhibit the Induced Amyloid β Aggregation for Alzheimer's Disease Therapy" [Heliyon 10 (2024) E23563]." Heliyon, vol. 11, no. 16, 2025, p. e44134, https://doi.org/10.1016/j.heliyon.2025.e44134.